Literature DB >> 12966224

GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions.

R Filipovic1, I Jakovcevski, N Zecevic.   

Abstract

Chemokines, small proinflammatory cytokines, are involved in migration of inflammatory cells, but also have a role in normal central nervous system development. One chemokine, growth-related oncogene-alpha (GRO-alpha) and its receptor CXCR2, are involved in proliferation and migration of oligodendrocyte progenitors in rats. Here we studied the regional and cell type-specific expression of GRO-alpha and CXCR2 in the human telencephalon at midgestation, the time that oligodendrocytes are being generated in the human brain. Our results showed that both GRO-alpha and CXCR2 are predominately expressed by oligodendrocyte progenitors and activated microglial cells in the highly proliferative subventricular zone. This cellular and regional localization suggests that GRO-alpha/CXCR2 may play a role in human oligodendrocyte proliferation and subsequent migration. We also studied the expression of GRO-alpha and CXCR2 in brain sections of multiple sclerosis (MS) patients. Consistent with their role in the inflammatory process of MS, both GRO-alpha and CXCR2 were expressed in activated microglia localized on the border of MS lesions. However, neither GRO-alpha nor CXCR2 were present in early oligodendrocyte progenitors, a finding that may partially explain why remyelination is not more efficient in MS. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966224     DOI: 10.1159/000072275

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  41 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Contributions of cortical subventricular zone to the development of the human cerebral cortex.

Authors:  Nada Zecevic; Yanhui Chen; Radmila Filipovic
Journal:  J Comp Neurol       Date:  2005-10-17       Impact factor: 3.215

6.  Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1.

Authors:  Kakuri M Omari; Sarah E Lutz; Laura Santambrogio; Sergio A Lira; Cedric S Raine
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

7.  Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.

Authors:  Adarsh S Reddy; Joong H Kim; Jacqueline A Hawkins-Salsbury; Shannon L Macauley; Elisabeth T Tracy; Carole A Vogler; Xialin Han; Sheng-Kwei Song; David F Wozniak; Stephen C Fowler; Robyn S Klein; Mark S Sands
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

8.  GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Massimo D'Amore; Raffaella De Lucro; Domenico Ribatti
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 9.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

Review 10.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.